Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Tsart MCL 50 Tablet ER

Prescription Icon
Prescription Required

Marketer

Alkem Laboratories Ltd

Salt Composition

Cilnidipine (10mg) + Metoprolol Succinate (47.50mg) + Telmisartan (40mg)

Overview Tsart MCL 50 Tablet ER

Tsart MCL 50 Extended-Release tablets combine medications to manage hypertension when single-drug therapy proves insufficient. This treatment lowers elevated blood pressure, mitigating the risk of future strokes and heart attacks. The tablets can be taken with food at any time of day, but consistent daily timing is recommended. Continue taking them as prescribed, even if feeling well, as hypertension often presents asymptomatically; premature cessation can worsen the condition. Lifestyle modifications, including regular exercise, weight management, and a balanced diet, complement this medication's effectiveness. Adhere strictly to your physician's instructions. Potential side effects include nausea, altered taste perception, pharyngitis, backache, and edema. Elevating your legs can alleviate ankle swelling. Avoid potassium-rich foods and supplements during treatment. Regular monitoring of blood pressure, renal function, blood glucose, and electrolytes is likely. Inform your doctor of any pre-existing liver or kidney disease before commencing treatment. Pregnant or lactating individuals should seek medical counsel prior to use. Disclose all current medications, especially those for hypertension or cardiac conditions, to your physician.

Uses of Tsart MCL 50 Tablet ER

Elevated arterial blood pressure

Major Benefits of Tsart MCL 50 Tablet ER:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Tsart MCL 50 Tablet ER should be administered with a meal.

Common Side effects of Tsart MCL 50 Tablet ER:

  • Nausea
  • Taste change
  • Diarrhea
  • Headache
  • Dizziness
  • Weakness
  • Ankle swelling
  • Flushing (sense of warmth in the face, ears, neck and trunk)
  • Edema (swelling)
  • Slow heart rate
  • Cold extremities
  • Decreased blood pressure
  • Throat infection

How to use Tsart MCL 50 Tablet ER:

Consume this medication according to your doctor's prescribed dosage and schedule. Ingest the tablet whole; do not crush, chew, or divide it. Tsart MCL 50 Tablet ER should be administered with a meal.

How Tsart MCL 50 Tablet ER works:

Tsart MCL 50 Extended-Release Tablet comprises a three-drug formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Tsart MCL 50 Tablet ER and alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Tsart MCL 50 tablets pose a confirmed risk to fetal development and should not be taken during pregnancy. In exceptional circumstances involving a life-threatening condition, a physician might prescribe them if the potential benefits outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on the compatibility of Tsart MCL 50 Tablet ER with breastfeeding is currently lacking. Seek medical advice from your physician.

DrivingDrivingUNSAFE

Extended-release Tsart MCL 50 tablets can cause drowsiness, blurred vision, and dizziness, impairing alertness. Driving should be avoided if these effects are experienced.

KidneyKidneyCONSULT YOUR DOCTOR

Insufficient data exists regarding Tsart MCL 50 Tablet ER use in individuals with renal impairment. Physician consultation is advised.

LiverLiverCAUTION

Patients with hepatic impairment should exercise caution when using Tsart MCL 50 Tablet ER; dosage modification may be necessary. Consult a physician for guidance. Tsart MCL 50 Tablet ER is contraindicated in individuals with severe liver dysfunction.

What if you forget to take Tsart MCL 50 Tablet ER :

Should you forget a Tsart MCL 50 Tablet ER dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Tsart MCL 50 Tablet ER

LabelValue
Addictive None.
Medication Classification Heart-related
Tsart MCL 50 Tablet ER
131
MRP 159
17% off